Health Financing - Publications - Faculty & Research - Harvard Business School

Filter Results: (816)

Filter Results: (816)

Show Results For

← Page 15 of 816 Results →

Sort by

Are you looking for?

→Search All HBS Web

January 2023
Case

Thomas Buberl: Refounding AXA

By: Hubert Joly, Mihir Desai and Amram Migdal

In 2022, AXA and its CEO Thomas Buberl faced new types of challenges, including systemic risks such as climate change, geopolitical instability, public health crises, and social tensions caused by economic risks. AXA was one of the world’s largest insurers. Since... View Details

January 2018 (Revised April 2021)
Case

Capital Allocation at HCA

By: W. Carl Kester and Emily R. McComb

In early 2017, HCA Holdings, an investor-owned hospital management company, faced a strategically important capital allocation decision. After the exit of its private equity sponsors in 2016, HCA had to determine how best to allocate its substantial annual free cash... View Details

Keywords: Capital Allocation; Cash Distribution Policy; Dividends; Share Repurchases; Growth Strategy And Execution; Growth Investing; Capital Expenditures; Debt Management; Debt Reduction; Debt Policy; Hospital Management; Investor-owned Hospital Chains; Capital Budgeting; Capital Structure; Cash Flow; Corporate Finance; Decision Choices and Conditions; Health Industry; United States

24 Jan 2017
First Look

First Look at New Research: January 24, 2017

Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=52122 January 2017 Strategic Finance Managing Healthcare Costs and Value By: Kaplan, Robert S., Michael E. Porter, and Mark L. Frigo Abstract—Rising View Details

Keywords: Sean Silverthorne

January 2017
Supplement

Terrapin Laboratory: Exercise

By: Joseph B. Fuller and Christopher Payton

In this exercise, we examine the capital requirements of Terrapin Laboratory as they contemplate entering into a new market segment. The company is faced with two potential financing options which have different effects on the ownership structure of the company.... View Details

Keywords: Business Growth; Entrepreneurial Management; Growth Strategy; Market Entry; Venture Capital; Market Entry and Exit; Entrepreneurship; Health Testing and Trials; Growth and Development Strategy; Pharmaceutical Industry

16 Aug 2024
In Practice

Election 2024: What's at Stake for Business and the Workplace?

and the International Economy Unit. Elisabeth Kempf: Political views shape economic outlook Political views influence the perception of economic reality among finance professionals. In a study linking credit rating analysts to party... View Details

Keywords: by Rachel Layne

September 2023
Case

Healthy.io: The Negotiation for the Medical Selfie

By: Amit Goldenberg and Kumba Sennaar

Healthy.io, an Israeli digital health company, prepares to enter the U.S. market with its chronic kidney disease test. A product safety approval is delayed, putting the company’s cash runway at risk. How should the CEO negotiate his offer to insurance companies ahead... View Details

Keywords: Negotiation; Entrepreneurship; Venture Capital; Operations; Business Startups; Market Entry and Exit; Health Industry; Israel; United Kingdom; United States

October 2012 (Revised October 2016)
Case

Predilytics

By: Robert F. Higgins and Annelena Lobb

The management team at Predilytics, a healthcare analytics firm, must decide whether to accept a Series A venture capital financing deal. The company provided analytic services to healthcare plans, typically Medicare Advantage plans, in efforts to draw conclusions from... View Details

Keywords: Analytics; Healthcare; Medicare; Health Care and Treatment; Mathematical Methods; Health Industry; New England; United States

01 Jul 2010
Working Paper Summaries

Cyclicality of Credit Supply: Firm Level Evidence

Keywords: by Bo Becker & Victoria Ivashina; Banking

November 2009 (Revised August 2010)
Case

NovoCure Ltd.

By: William A. Sahlman and Sarah Flaherty

Venture capitalist William Doyle must raise $35 million for a portfolio company with a promising, novel cancer therapy, just as global capital markets are imploding in the fall of 2008. NovoCure, Ltd., has developed an electrical-field-based therapy, called Tumor... View Details

Keywords: Financial Crisis; Entrepreneurship; Venture Capital; Investment; Health Care and Treatment; Health Testing and Trials; Technological Innovation; Financial Services Industry

March 2022 (Revised August 2022)
Case

Proximie: Using XR Technology to Create Borderless Operating Rooms

By: Ariel D. Stern and Alpana Thapar

In mid-January 2022, Nadine Hachach-Haram, founder and CEO of Proximie, was thinking about the company’s growth plans. Launched in 2016, Proximie was a platform that enabled clinicians, proctors, and medical device company personnel to be virtually present in operating... View Details

Keywords: Growth and Development Strategy; Technological Innovation; Partners and Partnerships; Strategic Planning; Health Care and Treatment; Analytics and Data Science; Digital Platforms; Health Industry; Lebanon; United Kingdom; United States

December 2004 (Revised March 2007)
Case

Cutlass Capital, L.P.

By: Richard G. Hamermesh and Brian DeLacey

David Hetz and Jon Osgood are forming a new venture capital fund in 2001 to invest in health care start-ups. Describes their fundraising activities at a time when venture capital investing has reached an all-time high. Although their background skills and experiences... View Details

Keywords: Venture Capital; Negotiation Process; Entrepreneurship; Investment Funds; Health Care and Treatment; Business Startups; Health Industry; United States

May 2021
Case

Inclusive Innovation at Mass General Brigham

By: Katherine Baldiga Coffman and Olivia Hull

Massachusetts General Brigham (MGB) Chief Innovation Officer Christopher Coburn had overseen a period of exciting transformation and growth in healthcare innovation at MGB. In November 2019, the health system was the largest recipient of National Institutes of Health... View Details

March 2012 (Revised October 2012)
Case

Against the Grain: Jim Teague in Tanzania (A)

By: Karthik Ramanna

Loan officer Jim Teague discovers his agro-processor client has a serious health-code violation just days before a disbursement is due. Proceeding with the loan could jeopardize the health of thousands of customers and put his employer at serious risk. But withholding... View Details

Keywords: Agribusiness; Financing and Loans; Health; Risk Management; Developing Countries and Economies; Agriculture and Agribusiness Industry; Tanzania

Article

Are Cost Advantages from a Modern Indian Hospital Transferable to the United States?

By: R. S. Kaplan, F. Erhun, V.G. Narayanan, B. Mistry and K. Brayton, et al

We use time-driven activity-based costing to estimate the cost of personnel and space for an elective coronary artery bypass graft (CABG) surgery at two U.S. hospitals, Intermountain and Baylor Heart, and Narayana Health (NH), in India. All three hospitals use modern... View Details

Keywords: Time-Driven Activity-Based Costing; Health Care and Treatment; Cost; Organizational Structure; Performance Efficiency; India; United States

August 1998
Case

Record Masters

By: William A. Sahlman, Michael J. Roberts and Laurence E. Katz

Kent Dauten, a former general partner at the Chicago private equity firm of Madison Dearborn Partners, has engaged in a search to personally sponsor a buyout in which he can play an active management role. He has received a selling memorandum for Record Masters, a... View Details

Keywords: Risk and Uncertainty; Leveraged Buyouts; Valuation; Negotiation Deal; Investment

10 Dec 2024
Interview

A New Model for Funding Healthcare Innovation

By: Regina E. Herzlinger and Duke Rohlen

Ajax Health founder Duke Rohlen (HBS MBA 2001) and HBS Professor Regina Herzlinger join host Brian Kenny to discuss the key success factors for both start-up and established medical technology firms. The case “Ajax Health: A New Model for Medical Technology Innovation”... View Details

Keywords: Entrepreneurship; Innovation and Invention; Business Model; Private Equity; Health Industry

20 Jul 2010
First Look

First Look: July 20

rights on firms' external finance constraints via generalized method of moments (GMM) estimation of an augmented investment Euler equation developed by Whited and Wu (2006). Using a large sample of U.S. firms during the period from 1995... View Details

Keywords: Martha Lagace

November 2020
Case

Valuing Celgene's CVR

By: Benjamin C. Esty and Daniel Fisher

When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage... View Details

Keywords: Mergers and Acquisitions; Value; Valuation; Judgments; Decision Making; Cash Flow; Financial Instruments; Cognition and Thinking; Pharmaceutical Industry; Biotechnology Industry; United States

October 1986 (Revised November 1989)
Case

Becton Dickinson & Co.: VACUTAINER Systems Division

By: Frank V. Cespedes

Concerns negotiations between managers of Becton Dickinson's (BD) VACUTAINER division (which manufactures and sells blood collection products) and managers of a large hospital buying group. Recent changes in the health care industry are the background for the... View Details

Keywords: Distribution; Negotiation Participants; Negotiation Process; Price; Sales; Health Industry; Health Industry; Health Industry; United States

December 12, 2023
Article

Prices for Common Services at Quaternary vs Nonquaternary Hospitals

By: Brandon W. Yan, Maximilian J. Pany and Leemore S. Dafny

Using commercial health insurance claims data from 2017-2019, we assessed whether quaternary hospitals charged higher prices for common, unspecialized services also offered by nonquaternary hospitals. We found quaternary-hospital price premiums of 8.2 percent, on... View Details

Keywords: Price; Health Care and Treatment; Insurance; Markets; Health Industry

Find at Harvard

←
15
16
…
40
41
→